Sermorelin 10mg
(GHRH)

Premium Grade | UK Supply

(Pentapeptide, 5 amino acids)

 

Brief Summery

Sermorelin is a peptide research compound studied in laboratory settings for its interaction with growth hormone releasing hormone pathways and related endocrine signalling systems. It is commonly examined in controlled investigational models focused on pituitary response activity, receptor mediated pathway analysis, and comparative peptide mechanism research. Within scientific supply catalogues, Sermorelin is valued for in vitro and preclinical studies involving signalling dynamics, secretion related marker observation, and structured peptide design investigation. Its role in research centres on analytical evaluation, documented laboratory handling, and consistent experimental planning, making it suitable for professional scientific environments requiring clear, research focused peptide supply standards.

 

Sermorelin is a peptide analogue of growth hormone releasing hormone (GHRH), consisting of the biologically active 29 amino acid fragment of endogenous GHRH. It is specifically designed to stimulate the natural, pulsatile secretion of growth hormone via activation of GHRH receptors within the hypothalamic pituitary axis. By acting upstream rather than replacing growth hormone directly, Sermorelin allows researchers to investigate physiological growth hormone regulation under controlled conditions. In scientific research, Sermorelin is valued for its ability to support endogenous growth hormone signalling while preserving intrinsic hormonal feedback mechanisms. Its shorter structure and rapid clearance profile make it particularly useful for studying growth hormone release patterns, receptor sensitivity, and neuroendocrine communication. As a result, Sermorelin remains a foundational compound in peptide research focused on metabolic regulation, endocrine balance, and age related hormonal dynamics.

 

Scientific Background

Sermorelin is derived from the first 29 amino acids of native human growth hormone–releasing hormone, a region responsible for full biological activity at the GHRH receptor. Unlike extended or modified GHRH analogues, Sermorelin closely mirrors the natural hormone sequence, resulting in rapid receptor binding and short biological persistence. This feature allows researchers to examine acute growth hormone release events and temporal hormone signalling with high precision. Upon receptor binding at the anterior pituitary, Sermorelin activates intracellular signalling pathways primarily involving cyclic AMP (cAMP) and calcium mobilisation. These pathways stimulate the synthesis and pulsatile secretion of growth hormone from somatotroph cells, leading to downstream modulation of insulin like growth factor 1 (IGF 1). The GH–IGF 1 axis plays a central role in cellular growth, protein synthesis, metabolic regulation, and tissue maintenance, making Sermorelin a valuable tool for endocrine pathway research. Crucially, Sermorelin does not suppress endogenous hormone production or override natural regulatory systems. Negative feedback via somatostatin and IGF 1 remains intact, allowing for the study of adaptive endocrine responses, receptor regulation, and long term hormonal signalling integrity.

 

Research Applications

Sermorelin is extensively researched within endocrinology and metabolic science, particularly in studies examining growth hormone secretion patterns and hypothalamic pituitary axis function. Researchers use Sermorelin to investigate growth hormone deficiency models, age associated declines in GH output, and the responsiveness of pituitary receptors to physiological stimulation. In metabolic research, Sermorelin is explored for its indirect effects on lipid metabolism, glucose regulation, and energy balance through growth hormone and IGF 1 modulation. These properties make it relevant in laboratory studies focused on metabolic efficiency, composition dynamics, and nutrient utilisation pathways. Additionally, Sermorelin is utilised in research exploring cellular repair mechanisms, protein turnover, and tissue maintenance processes linked to growth hormone signalling. Its short acting, highly physiological profile allows for repeated and controlled experimental use, making it particularly valuable in long term studies assessing endocrine adaptability, hormonal rhythm restoration, and growth hormone signalling fidelity.

 

Technical Specifications

• Contents: 10mg Sermorelin
• Form: Lyophilized powder
• Purity: >99% (HPLC Verified)
• Molecular Formula: C₁₄₉H₂₄₆N₄₄O₄₂S
• Sequence: Tyr-Ala-Asp-Ala-Ile-Phe-Thr-Asn-Ser-Tyr-Arg-Lys-Val-Leu-Gly-Gly-Gln-Glu-Ser-Asn-Ile-Asp-Leu-Arg-Gln-Gln-Gly-Gly-Gly-Gly
• Peptide Length: 29 Amino-Acids
• pH Range: 4.0-7.5
• Storage: Store between 2°C and 8°C

Note: Reconstitute with 50% Bacteriostatic (BAC) water and 50% Acetic Acid for best results.

Related Research Compounds

Tesamorelin 10mg
CJC-1295+DAC 5mg
Hexarelin 5mg

 

Disclaimer

For research purposes only, Not for human consumption.